P PRIVIA HEALTH GROUP INC
| Market Cap | $2.62B |
| P/E Ratio | 117.83 |
| Forward P/E | 17.66 |
| Dividend Yield | — |
| Beta | 0.87 |
| 52W Range | $18.86 - $26.40 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Health Information Services |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Henry Ellenbogen Durable Capital Partners | 2.71% | $286.60M | 12,087,843 | Add 3.39% |
Insider Trading
| Insider Name of the company insider who made the trade 21 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Mehrotra ParthChief Executive Officer | Sale | 26,509 | $22.11 | $586.11K | 16 Mar 2026 | 16 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 6,391 | $22.11 | $141.31K | 16 Mar 2026 | 16 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 6,565 | $21.52 | $141.28K | 13 Mar 2026 | 12 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 27,229 | $21.52 | $585.97K | 13 Mar 2026 | 12 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 6,453 | $21.90 | $141.32K | 12 Mar 2026 | 12 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 26,763 | $21.90 | $586.11K | 12 Mar 2026 | 12 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 21,097 | $22.71 | $479.11K | 10 Mar 2026 | 10 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 5,829 | $22.84 | $133.13K | 09 Mar 2026 | 06 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 18,865 | $22.84 | $430.88K | 09 Mar 2026 | 06 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 1,219 | $23.37 | $28.49K | 09 Mar 2026 | 06 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 21,915 | $22.84 | $500.54K | 09 Mar 2026 | 06 Mar 2026 |
| Fargis Edward CEVP & General Counsel | Sale | 4,949 | $22.84 | $113.04K | 09 Mar 2026 | 06 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 5,177 | $23.15 | $119.85K | 06 Mar 2026 | 06 Mar 2026 |
| Mehrotra ParthChief Executive Officer | Sale | 21,440 | $23.15 | $496.34K | 06 Mar 2026 | 06 Mar 2026 |
| Fargis Edward CEVP & General Counsel | Sale | 4,394 | $23.15 | $101.72K | 06 Mar 2026 | 06 Mar 2026 |
| Morris Matthew Shawn | Sale | 16,550 | $25.00 | $413.75K | 27 Feb 2026 | 02 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 7,697 | $25.05 | $192.81K | 27 Feb 2026 | 02 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 5,361 | $25.00 | $134.03K | 26 Feb 2026 | 02 Mar 2026 |
| Morris Matthew Shawn | Sale | 7,788 | $24.99 | $194.62K | 26 Feb 2026 | 02 Mar 2026 |
| Mountcastle DavidEVP & Chief Financial Officer | Sale | 23,887 | $25.03 | $597.89K | 12 Dec 2025 | 16 Dec 2025 |
| Morris Matthew Shawn | Sale | 13,647 | $25.01 | $341.31K | 12 Dec 2025 | 16 Dec 2025 |
Frequently Asked Questions
What is PRVA stock price today?
PRIVIA HEALTH GROUP INC (PRVA) is currently trading at $21.21. The stock has a 52-week range of $18.86 to $26.40 and a market capitalization of $2.62B.
Is PRVA a good stock to buy in 2026?
PRIVIA HEALTH GROUP INC has a P/E ratio of 117.8 (forward P/E: 17.7), a dividend yield of none, and 1-year performance of -4.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling PRVA stock?
There have been 21 insider transactions for PRVA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has PRVA stock performed over the past year?
PRIVIA HEALTH GROUP INC (PRVA) has returned -4.6% over the past 12 months. The stock traded between $18.86 and $26.40 during this period, and is currently at $21.21.
Which hedge funds own PRVA (PRIVIA HEALTH GROUP INC)?
1 tracked hedge funds currently hold PRVA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is PRVA's market cap and valuation?
PRIVIA HEALTH GROUP INC (PRVA) has a market capitalization of $2.62B. The trailing P/E ratio is 117.8 and forward P/E is 17.7. The stock is classified in the Healthcare sector.
What is PRVA's revenue and profitability?
PRIVIA HEALTH GROUP INC reported revenue of $2.12B with net income of $22.92M and a profit margin of 0.01%. The stock has a beta of 0.87.
What sector is PRVA in and who are its biggest institutional holders?
PRIVIA HEALTH GROUP INC (PRVA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.